Thalidomide-O-amido-C3-NH2 (TFA) CAS 2022182-58-5

Purity 97%+In StockPharmaceutical Standards
CAS No.2022182-58-5
Molecular FormulaC18H20N4O6
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

Thalidomide-O-amido-C3-NH2 (TFA) CAS 2022182-58-5 chemical structure

Description

CATO manufactures Thalidomide-O-amido-C3-NH2 (TFA) under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

CATO supplies Thalidomide-O-amido-C3-NH2 (TFA) (CAS 2022182-58-5), a certified reference material (molecular formula C18H20N4O6C2HF3O2, MW 502.40 g/mol) for analytical method development and quality control.

Owing to a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution, Thalidomide-O-amido-C3-NH2 (TFA) is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 502.40 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

Physical & Chemical Properties

Molecular FormulaC18H20N4O6 C2HF3O2
Molecular Weight502.40 g/mol
AppearancePale yellow to yellow crystalline powder. (slight halide-like odor, low volatility)
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)11.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1996
Halogen ContentF-containing
Nitrogen Atoms4

Related Thalidomide Standards

Recommended Standards

Why CATO?